Literature DB >> 3019877

Surface markers of NK cells in peripheral blood of patients with cirrhosis and hepatocellular carcinoma.

T Nakajima, N Mizushima, J Nakamura, K Kanai.   

Abstract

The surface markers and NK activity of blood lymphocytes in 38 normal controls, 57 cirrhotic patients and 22 cirrhotics with hepatocellular carcinoma were studied by the flow cytofluorometry using monoclonal antibodies. A reduction of OKM1+ cells was remarkable in cirrhotics, and a further decrease in HNK-1+ cells as well as OKM1+ cells was observed in cirrhotics with hepatocellular carcinoma, accompanied by depression of NK activity. We postulate that the decreased NK activity in these patients may result from the disturbed maturation of NK cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3019877     DOI: 10.1016/0165-2478(86)90117-3

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  7 in total

Review 1.  NK cells and cancer: you can teach innate cells new tricks.

Authors:  Maelig G Morvan; Lewis L Lanier
Journal:  Nat Rev Cancer       Date:  2016-01       Impact factor: 60.716

2.  Low serum levels of alpha-interferon, gamma-interferon, and interleukin-2 in alcoholic cirrhosis.

Authors:  M M Vicente-Gutiérrez; A Diez Ruiz; B Gil Extremera; J M Bermúdez García; F Gutiérrez Gea
Journal:  Dig Dis Sci       Date:  1991-09       Impact factor: 3.199

Review 3.  Targeting natural killer cells in solid tumors.

Authors:  Guillaume Habif; Adeline Crinier; Pascale André; Eric Vivier; Emilie Narni-Mancinelli
Journal:  Cell Mol Immunol       Date:  2019-03-25       Impact factor: 11.530

4.  CD56dim CD16- Natural Killer Cell Profiling in Melanoma Patients Receiving a Cancer Vaccine and Interferon-α.

Authors:  Lazar Vujanovic; Christopher Chuckran; Yan Lin; Fei Ding; Cindy A Sander; Patricia M Santos; Joel Lohr; Afshin Mashadi-Hossein; Sarah Warren; Andy White; Alan Huang; John M Kirkwood; Lisa H Butterfield
Journal:  Front Immunol       Date:  2019-01-29       Impact factor: 7.561

Review 5.  Strategies to Optimise Oncolytic Viral Therapies: The Role of Natural Killer Cells.

Authors:  Elaine Y L Leung; Iain A McNeish
Journal:  Viruses       Date:  2021-07-26       Impact factor: 5.048

Review 6.  Natural killer cells: the next wave in cancer immunotherapy.

Authors:  Xin Chen; Lei Jiang; Xuesong Liu
Journal:  Front Immunol       Date:  2022-07-27       Impact factor: 8.786

Review 7.  Positive & Negative Roles of Innate Effector Cells in Controlling Cancer Progression.

Authors:  Dorian Stolk; Hans J van der Vliet; Tanja D de Gruijl; Yvette van Kooyk; Mark A Exley
Journal:  Front Immunol       Date:  2018-09-21       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.